Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2021

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Discontinued Operations

The following tables summarize the major classes of assets and liabilities related to the discontinued operations of the TransCore, Zetec and CIVCO Radiotherapy businesses, as reported in the Condensed Consolidated Balance Sheets:

	September 30, 2021 (1)		December 31, 2020
Accounts receivable, net	$	86.8	$	117.3
Inventories, net	53.8		33.3
Unbilled receivables	154.6		168.9
Goodwill	428.5		—
Other intangible assets, net	37.8		—
Other current assets	72.1		4.7
Current assets held for sale	833.6		324.2
Goodwill	—		429.2
Other intangible assets, net	—		38.7
Other assets	—		53.7
Assets held for sale	$	—	$	521.6
Accounts payable	$	49.7	$	50.7
Accrued compensation	30.2		23.5
Deferred taxes	25.2		—
Other current liabilities	63.5		46.6
Current liabilities held for sale	168.6		120.8
Deferred taxes	—		31.0
Other liabilities	—		33.1
Liabilities held for sale	$	—	$	64.1

(1) All assets and liabilities held for sale were classified as current as it is probable the sale of TransCore, Zetec and CIVCO Radiotherapy will be completed within one year.

The following table summarizes the major classes of revenue and expenses constituting net income from discontinued operations attributable to the TransCore, Zetec and CIVCO Radiotherapy businesses:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
Net revenues	$	158.6	$	167.9	$	472.1	$	503.2
Cost of sales	91.3		101.9		280.2		296.7
Gross profit	67.3		66.0		191.9		206.5
Selling, general and administrative expenses(1)	25.6		28.9		87.8		86.6
Income from operations	41.7		37.1		104.1		119.9
Other income (expense), net	0.2		(0.2)		1.4		0.2
Earnings before income taxes	41.9		36.9		105.5		120.1
Income taxes	12.2		9.5		23.4		26.7
Net earnings from discontinued operations	$	29.7	$	27.4	$	82.1	$	93.4

(1) Includes stock-based compensation expense of $1.4 and $1.2 for the three months ended September 30, 2021 and 2020, respectively, and $3.2 and $3.5 for the nine months ended September 30, 2021 and 2020, respectively. Stock-based compensation for discontinued operations was previously reported as a component of unallocated corporate general and administrative expenses.